tiprankstipranks

Antony A Riley Insider Profile

4 Followers
Antony A Riley, CFO at Krystal Biotech, holds 30.78K shares in Forte Biosciences (Ticker: FBRX), holds 9.05K shares in Krystal Biotech (Ticker: KRYS). Most recently, Antony A Riley Bought ― shares of Forte Biosciences on Nov 22, 2024 for an estimated value of 124.95K.
tipranks
Antony A Riley

Antony A Riley
Krystal Biotech (KRYS)
CFO

Ranked #6,085 out of 99,335 Corporate Insiders

Profitable Transactions

100%
3 out of 3 Profitable Transactions

Average Return

+139.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
77.41%
22.59%
A breakdown of Antony A Riley's holdings

Insider Roles

Krystal Biotech
(KRYS)
CFO
Forte Biosciences
(FBRX)
CFO
Roles that Antony A Riley holds in companies

Most Profitable Insider Trade

Stock:
Krystal Biotech
(KRYS)
Rating:Informative Buy
Date:May 24, 2018 - May 24, 2019
Return:+218.60%
The most profitable trade made by Antony A Riley

Antony A Riley's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Krystal Biotech
Nov 21, 2019
CFO
Uninformative Buy
61.56K
$1.65M
Forte Biosciences
Nov 22, 2024
CFO
Informative Buy
124.95K
$481.34K
List of latest transactions for each holding click on a transaction to see Antony A Riley's performance on stock

Antony A Riley insider profile FAQ

What is the percentage of profitable transactions made by Antony A Riley?
The percentage of profitable transactions made by Antony A Riley is 100%.
    What is the average return per transaction made by Antony A Riley?
    The average return per transaction made by Antony A Riley is 139.10%.
      What stocks does Antony A Riley hold?
      Antony A Riley holds: KRYS, FBRX stocks.
        What was Antony A Riley’s latest transaction?
        Antony A Riley latest transaction was an Informative Buy of $124.95K.
          What was Antony A Riley's most profitable transaction?
          Antony A Riley’s most profitable transaction was an Informative Buy of KRYS stock on May 24, 2018. The return on the trade was 218.60%.
            What is Antony A Riley's role in Krystal Biotech?
            Antony A Riley's role in Krystal Biotech is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.